Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors

• Simon Wöhrle,

  Current address: Boehringer Ingelheim RCV GmbH & Co. KG., Vienna, Austria

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Andreas Weiss ,

  Contributed equally to this work with: Andreas Weiss, Moriko Ito, Audrey Kauffmann, Masato Murakami

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Moriko Ito ,

  Contributed equally to this work with: Andreas Weiss, Moriko Ito, Audrey Kauffmann, Masato Murakami

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Audrey Kauffmann ,

  Contributed equally to this work with: Andreas Weiss, Moriko Ito, Audrey Kauffmann, Masato Murakami

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Masato Murakami ,

  Contributed equally to this work with: Andreas Weiss, Moriko Ito, Audrey Kauffmann, Masato Murakami

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Zainab Jagani,

  Affiliation Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Anne Thuery,

  Current address: Centre for Immunology and Infection, Department of Biology, University of York, York, United Kingdom

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Beatrice Bauer-Probst,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Flavia Reimann,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Christelle Stamm,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Astrid Pornon,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Vincent Romanet,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Vito Guagnano,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Thomas Brümmendorf,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• William R. Sellers,

  Affiliation Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Francesco Hofmann,

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• Charles W. M. Roberts,

  Affiliation Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children’s Hospital Boston, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Diana Graus Porta

  * E-mail: diana.graus_porta@novartis.com

  Affiliation Novartis Institutes for BioMedical Research, Basel, Switzerland

  ⨯
• [ view all ]
• [ view less ]